[Evaluation of one month treatment with flunisolide in perennial allergic rhinitis].
The study was carried out on a group of 20 patients ages 10-44. Syntaris was administered twice daily in a total dose of 100 mcg. Rhinitis symptoms were assessed by subjective scoring (graded 0-3) and by objective measurement of nasal airflow using anterior rhinomanometry. Syntaris proved to be a safe and effective drug particularly in improving nasal patency.